RxDoctor Payments Data

Andrew Keller

Nurse Practitioner · Knoxville, TNNPI 1508154915

Payments from drug & device makers

$6,987in general payments, 2019–2025

Across 180 payments — averaging $38.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$2K
  • MML US, Inc.$1K
  • AstraZeneca$483
  • Collegium Pharmaceutical, Inc.$385
  • Boston Scientific$289
  • Otsuka America Pharmaceutical, Inc.$271
  • plus $2K from 29 others

What the payments were for

  • Travel & lodging$1,35719%
  • Food & beverage$4,62566%
  • Education$1,00614%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,987 in reported general payments places this provider in the 90th percentile of 2,662 nurse practitioner providers in Tennessee.

See all nurse practitioner providers in Tennessee

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen1,045$42,036
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen681$36,115
Buprenorphine109$26,882
Nurtec OdtRimegepant Sulfate12$22,198
LinzessLinaclotide33$17,469
BelbucaBuprenorphine Hcl25$15,942
Gabapentin722$10,662
Calcipotriene31$8,807
MovantikNaloxegol Oxalate22$8,565
Emgality PenGalcanezumab-Gnlm12$8,561
Oxycodone Hcl359$6,195
Tizanidine Hcl339$4,698
Lidocaine62$4,693
Pregabalin183$3,816
Cyclobenzaprine Hcl198$2,606

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate$30$27,797138 claims
AbbVieLinzess$221$17,46933 claims
Collegium Pharmaceutical, Inc.Belbuca$385$15,94225 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,662 nurse practitioner providers in Tennessee.

Other nurse practitioner in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →